Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,864 shares at $263.67 ($1.3M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
Open-market sale of $1.3M VRTX by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.42 | 300 | $78K | 6.1% |
| 2 | $263.67 | 381 | $100K | 7.8% |
| 3 | $263.67 | 381 | $100K | 7.8% |
| 4 | $265.06 | 1,142 | $303K | 23.5% |
| 5 | $265.06 | 1,142 | $303K | 23.5% |
| 6 | $265.95 | 536 |
| $143K |
| 11.1% |
| 7 | $265.95 | 536 | $143K | 11.1% |
| 8 | $266.68 | 223 | $59K | 4.6% |
| 9 | $266.68 | 223 | $59K | 4.6% |
| Total | $264.96 avg | 4,864 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |